Css LLC Sarepta Therapeutics, Inc. Transaction History

Css LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $712,880 - $1.05 Million	6,700 New	6,700 $767,000
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $121,211 - $190,903	1,601 New	1,601 $177,000
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $213,412 - $266,843	-3,076 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $123,403 - $288,566	1,708 Added 124.85%	3,076 $229,000
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $96,681 - $137,629	770 Added 128.76%	1,368 $233,000
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $49,263 - $78,720	598 New	598 $58,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.